Latent Labs

Latent Labs is a biotechnology company focused on developing foundational artificial intelligence (AI) models to make biology programmable. The company’s mission is to exert control over molecular biology using generative AI, thereby transforming applications in health and sustainability.

Area of Activity and Technology

Latent Labs focuses on creating generative AI foundational models, known as Frontier Models, that simulate the fundamental elements of biology. This approach aims to transform biology from an observational science into an engineering discipline by modeling interactions between molecules. The company seeks to empower its partners with the ability to design novel antibodies, optimize existing enzymes, and advance genetic engineering using these models.

Latent-X Model

Latent Labs’ first frontier model, Latent-X, is an atom-level AI model designed for De Novo protein binder design.

• Design Features: The model generates binders for zero-shot and non-targeted proteins by solving geometric constraints of binding at the atomic level. This process involves constructing structures that adhere to the necessary biochemical rules—such as hydrogen bonding—for high binding affinity and specificity.
• Validation Results: In comprehensive laboratory experiments, Latent-X demonstrated success rates of 91–100% for macrocycles and picomolar-range binding affinities for mini-binders. The company states that these results surpass the performance of some previous state-of-the-art models.
• Therapeutic Modalities: The model has successfully designed various therapeutic binder modalities, initially focusing on macrocycles and mini-binders.

Latent Labs Platform

Latent-X is made accessible through the Latent Labs Platform. The platform enables users to perform workflows such as target loading, epitope selection, binder design, and computational ranking without writing any code. The company aims to extend access to its AI infrastructure to scientists who lack or have limited computational resources.

Corporate Information

Latent Labs was founded in 2023 by Dr. Simon Kohl. Prior to this, Kohl co-led the protein design team at Google DeepMind and served as a senior research scientist on the AlphaFold2 project.

In February 2025, the company emerged from stealth with a $50 million funding round co-led by Radical Ventures and Sofinnova Partners. Other investors include 8VC, Pillar VC, Kindred Capital, Isomer, and Flying Fish. Notable angel investors include Google Chief Scientist Jeff Dean and Anthropic CEO Dario Amodei.

The company is headquartered in London and San Francisco. Its team includes former co-developers of AlphaFold2 and experts from organizations such as DeepMind, Microsoft, Google, Stability AI, Exscientia, Mammoth Bio, Altos Labs and Zymergen. The founder and CEO is Simon Kohl.